Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionAndra AP-fonden
Latest Disclosed Ownership23,903 shares
Latest Disclosed Value $ 10,673,646
Andra AP-fonden reports 33.49% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 8, 2026 - Andra AP-fonden filed a 13F-HR form disclosing ownership of 23,903 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $10,673,646 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 35,940 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -33.49% during the quarter. The current value of the position is $10,680,577 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 23,903 -12,037 -33.49 10,674 -34.49 0.1272
2026-02-12 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 35,940 40 0.11 16,294 15.89 0.2013
2025-11-12 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 35,900 35,900 14,060 0.1797
2025-08-06 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -5,500 -100.00 0 -100.00
2025-05-13 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,500 -30,600 -84.76 2,667 -81.66 0.0437
2025-02-07 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 36,100 -5,500 -13.22 14,537 -24.86 0.2328
2024-11-12 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 41,600 -28,200 -40.40 19,347 -40.86 0.2849
2024-08-07 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 69,800 -12,000 -14.67 32,717 -4.32 0.5497
2024-05-13 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 81,800 58,800 255.65 34,193 265.39 0.6070
2024-02-15 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 23,000 5,800 33.72 9,358 56.46 0.4955
2023-11-09 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 17,200 -800 -4.44 5,981 -5.57 0.3526
2023-08-09 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 18,000 -16,600 -47.98 6,334 -41.90 0.1602
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 34,600 -9,400 -21.36 10,901 90,741.67 0.2836
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 44,000 -13,000 -22.81 13 -99.93 0.3851
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 57,000 -6,100 -9.67 16,504 -7.18 0.5408
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 63,100 -12,500 -16.53 17,781 7.10 0.5092
2022-02-15 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 75,600 4,100 5.73 16,602 28.01 0.3381
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 71,500 2,700 3.92 12,969 -6.51 0.2669
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 68,800 22,500 48.60 13,872 39.43 0.2833
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 46,300 -5,000 -9.75 9,949 -17.94 0.2193
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 51,300 20,800 68.20 12,124 46.07 0.2675
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 30,500 200 0.66 8,300 -5.64 0.2251
2020-08-06 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 30,300 6,200 25.73 8,796 53.37 0.2560
2020-05-13 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 24,100 1,600 7.11 5,735 16.42 0.2085
2020-02-10 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,500 4,300 23.63 4,926 59.78 0.1409
2019-11-19 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 18,200 0 0.00 3,083 -7.64 0.0916
2019-08-15 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 18,200 -10,700 -37.02 3,338 -37.21 0.0961
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 28,900 -7,400 -20.39 5,316 -24.01 0.1548
2018-10-16 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 36,300 2,000 5.83 6,996 20.00 0.1804
2018-08-17 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 34,300 -4,700 -12.05 5,830 -8.28 0.1576
2018-04-10 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 39,000 16,200 71.05 6,356 86.01 0.1647
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,800 900 4.11 3,417 2.61 0.0776
2017-10-31 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 21,900 12,300 128.12 3,330 169.20 0.0780
2017-08-08 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,600 9,600 1,237 0.0306
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -3,400 -100.00 0 -100.00
2017-02-13 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,400 -4,600 -57.50 250 -64.18 0.0068
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,000 -4,600 -36.51 698 -35.61 0.0187
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 12,600 4,900 63.64 1,084 77.12 0.0277
2016-05-04 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,700 2,100 37.50 612 -13.19 0.0160
2016-02-10 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,600 -1,500 -21.13 705 -4.60 0.0201
2015-11-12 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,100 0 0.00 739 -15.74 0.0216
2015-08-13 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,100 -1,700 -19.32 877 -15.51 0.0253
2015-05-14 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,800 -6,700 -43.23 1,038 -43.62 0.0294
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 15,500 -100 -0.64 1,841 5.08 0.0427
2014-11-12 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 15,600 -15,300 -49.51 1,752 -19.82 0.0411
2014-05-13 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 30,900 -1,400 -4.33 2,185 -8.96 0.0504
2014-02-05 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 32,300 -3,100 -8.76 2,400 -10.58 0.0566
2013-11-07 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 35,400 8,300 30.63 2,684 24.03 0.0684
2013-07-18 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 27,100 27,100 2,164 0.0563
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.